NCT00003467已完成2 期
Phase II Treatment of Adults With Recurrent Supratentorial Low Grade Glioma With Gliadel Wafers
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 68
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of carmustine in treating adults with recurrent supratentorial low-grade glioma.
详细描述
OBJECTIVES:
- Determine the antitumor activity of Gliadel wafers (carmustine) in the treatment of recurrent supratentorial low grade glioma.
- Assess the toxicity of this therapy in these patients.
OUTLINE: Patients are stratified by disease (fibrillary astrocytoma vs oligodendroglioma or mixed glioma).
Patients receive up to 8 Gliadel wafers (containing carmustine) implanted in the resected tumor cavity.
Patients are followed every 2 months.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade GliomasBrain and Central Nervous System TumorsNCT00003463Duke University
已完成
2 期
Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma MultiformeBrain and Central Nervous System TumorsNCT00003464Duke University50
已完成
2 期
Temozolomide in Treating Patients With Anaplastic OligodendrogliomaBrain and Central Nervous System TumorsNCT00003465Duke University60
已完成
2 期
Temozolomide in Treating Patients With Progressive Low-Grade GliomaBrain and Central Nervous System TumorsNCT00003466Duke University100
已完成
2 期
Temozolomide in Treating Patients With Brain MetastasesBrain and Central Nervous System TumorsNCT00005954Duke University